BIONET Corp. (TPEX:1784)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.00
+0.30 (0.50%)
Aug 19, 2026, 11:12 AM CST

BIONET Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
57.1851.4383.778.437.9726.62
Depreciation & Amortization
67.255.1238.3632.2834.3831.16
Other Amortization
7.227.227.27.328.677.68
Loss (Gain) From Sale of Assets
-0.05-0.02-0.39-0-0.010.03
Loss (Gain) From Sale of Investments
-0.57-1.56-2.33-2.635.35-0.21
Stock-Based Compensation
21.8424.4226.254.99-2.44
Provision & Write-off of Bad Debts
4.42.370.61.63.140.33
Other Operating Activities
-60.69-75.91-21.3919.4825.2812.3
Change in Accounts Receivable
33.9253.927.23-30.56-67.44-74.97
Change in Inventory
-25.8-44.52-25.8-8.8432.651.02
Change in Accounts Payable
2.9416.13-4.299.741.3419.94
Change in Unearned Revenue
57.5458.8562.9237.3523.332.32
Change in Other Net Operating Assets
-2.54-6.575.9914.8729.83-17.58
Operating Cash Flow
169.12148.04176.49153.194.6513.88
Operating Cash Flow Growth
3.77%-16.12%15.28%61.74%582.04%-81.16%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-92.31-123.62-101.35-20.04-28.87-10.17
Sale of Property, Plant & Equipment
0.480.450.3900.01-
Sale (Purchase) of Intangibles
-12.45-8.56-2.14-6.24-4.04-6.49
Investment in Securities
17.34170.33-668.79-383.2630.4313.14
Other Investing Activities
-2.42-3.23-6.26-0.39-0.44-1.06
Investing Cash Flow
-89.3735.37-778.15-409.93-2.91-4.59

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-903530--
Total Debt Issued
120903530--
Short-Term Debt Repaid
--85----
Long-Term Debt Repaid
--13.11-10.97-8.03-7.61-7.1
Total Debt Repaid
-33.82-98.11-10.97-8.03-7.61-7.1
Net Debt Issued (Repaid)
86.18-8.1124.0321.97-7.61-7.1
Issuance of Common Stock
6.966.9613.996.7-7.18
Repurchase of Common Stock
-56.03-61.94-40.71--41.25-6.66
Common Dividends Paid
-70.06-70.06-33.15-32.63-23.52-8.77
Other Financing Activities
-36.8-36.8641.29337.9320.48-0.25
Financing Cash Flow
-69.76-169.96605.46333.98-51.9-15.6

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.25-0.20.49-0.27-0.03-0.26
Net Cash Flow
10.2413.264.376.8839.82-6.56

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
76.8124.4275.15133.0565.783.71
Free Cash Flow Growth
26.47%-67.51%-43.52%102.27%1674.48%-92.08%
Free Cash Flow Margin
5.93%1.98%6.15%11.80%6.71%0.40%
Free Cash Flow Per Share
1.530.481.482.631.300.07
Levered Free Cash Flow
-126.26-101.03-23.0270.2132135.63
Unlevered Free Cash Flow
-124.73-100.09-22.2370.4732.29135.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.51.51.280.410.460.39
Cash Income Tax Paid
44.3244.3234.129.066.753.48
Change in Working Capital
72.5984.9944.4911.65-20.14-66.47